Skip to content
Governance Register

← US public companies

Spruce Biosciences, INC.

SEC CIK 1683553 · SPRB · last insider filing 2026-05-26

Directors (from insider filings)

NameCapacity as filedFilings
Spiegelman Daniel K Director filed 2020 - 2026
Grey Michael G Director · Executive Chairman filed 2020 - 2026
Simpson Camilla V Director filed 2020 - 2026
Barretto-Ko Percival Director filed 2023 - 2026
Walbert Keli Director filed 2025 - 2026
Ways Kirk Director · Interim Chief Medical Officer filed 2021 - 2026
Szwarcberg Javier B. Director · Chief Executive Officer filed 2022 - 2026
Aynechi Tiba Director filed 2020 - 2025
Muralidhar Bali Director filed 2020 - 2025
O'Donnell Niall Director filed 2020 - 2023
Chaya Moghrabi Dina Director filed 2020 - 2022
King Richard Director · Chief Executive Officer filed 2020 - 2021
Hansson Jonas Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Hooks Corwin Dale Chief Commercial Officer filed 2026 - 2026
Gharib Samir M. President & CFO filed 2020 - 2025
Charlton Ralph William III Chief Medical Officer filed 2022 - 2024
Dias Subaweerage Chief Medical Officer filed 2020 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.